Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions.
Journal Information
Full Title: Arch Virol
Abbreviation: Arch Virol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of interestAll authors declare no competing interests. Conflict of interest All authors declare no competing interests."
"This study was supported by a VIDI Grant (no. 91719300) from the Netherlands Organization for Scientific Research (NWO) to Q. Pan a grant from and the China Scholarship Council for funding Ph.D. fellowships to Yining Wang (no. 201903250082) and Pengfei Li (no. 201808370170). The authors thank Dr. Lia van der Hoek (Amsterdam UMC location AMC, University of Amsterdam, The Netherlands) for providing the stock of human coronavirus NL63. The authors also thank Dr. Bart Haagmans (Department of Viroscience, Erasmus MC) for providing the stock of SARS-CoV-2 and SARS-CoV-2 B.1.617.2 Delta variant."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025